NDC 67296-2300-01 - Hyoscyamine Sulfate SL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67296-2300
- Requested NDC
- 67296-2300-01
- Package NDCs from labels
- 67296-2300-1, 67296-2300-2, 67296-2300-01
- Manufacturer
- Redpharm Drug
- Effective date
- 2026-10-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hyoscyamine Sulfate SL - Redpharm Drug | Redpharm Drug | 2026-10-10 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Uretron D/S | METHENAMINE, SODIUM PHOSPHATE MONOBASIC, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals | ea74f1aa-2b4d-4ccf-e053-2995a90abab5 | 2025-12-18 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate TAB | HYOSCYAMINE SULFATE | QPharma, Inc. | fc7566e6-c043-fcd4-e053-6294a90a77e5 | 2025-12-16 | Warnings, Adverse reactions | F2R8V82B84 |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Uro-MP | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE | Method Pharmaceuticals, LLC | 1e1b0dee-1a3b-4846-a212-c9febb3fc17d | 2025-10-29 | Warnings, Adverse reactions | F2R8V82B84 |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| OSCIMIN | HYOSCYAMINE SULFATE | Larken Laboratories, Inc. | 8504adad-f6d0-4671-b655-4b62bf29a516 | 2025-10-21 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate ODT | HYOSCYAMINE SULFATE | Acella Pharmaceuticals, LLC | eef6babc-241f-40b6-b8c8-daa92bbd0a25 | 2025-10-21 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Laser Pharmaceuticals, LLC | b12f856f-7157-4aee-bf73-1fdcb4834ffc | 2025-10-17 | Warnings, Adverse reactions | F2R8V82B84 |
| OSCIMIN | HYOSCYAMINE SULFATE | Larken Laboratories, Inc. | 2d5fa637-0696-40fe-9bc1-fcb6f07a50f6 | 2025-10-16 | Warnings, Adverse reactions | 1046982 F2R8V82B84 |
| Hyoscyamine Sulfate SL | HYOSCYAMINE SULFATE | Acella Pharmaceuticals, LLC | 8aab1dce-0699-4866-8707-33b4e2177bdd | 2025-10-02 | Warnings, Adverse reactions | 42192-339 1046982 40331302-66d2-ddb4-e063-6394a90a8bd9 8aab1dce-0699-4866-8707-33b4e2177bdd F2R8V82B84 |
| Hyoscyamine Sulfate TAB | HYOSCYAMINE SULFATE | Acella Pharmaceuticals, LLC | 49fe1783-ab0c-4adb-869b-384121cf7f05 | 2025-10-02 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | ANI Pharmaceuticals, Inc. | 3859133e-88bd-4dd5-90a0-82b64347f1db | 2025-09-12 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | ANI Pharmaceuticals, Inc. | 48fa3d71-8c78-4f29-b1f0-ecac8c36473e | 2025-09-12 | Warnings, Adverse reactions | 1046982 F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | ANI Pharmaceuticals, Inc. | cdb8f10a-b426-448f-8991-7724ffa88cb5 | 2025-09-12 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | ANI Pharmaceuticals, Inc. | 66fdfc33-a7b9-465b-84f1-012cdf5517fd | 2025-09-12 | Warnings, Adverse reactions | F2R8V82B84 |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| UROGESIC BLUE | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | EDWARDS PHARMACEUTICALS, INC. | d820e42d-ad2b-4e11-907b-a94d698ca285 | 2025-08-13 | Warnings, Adverse reactions | F2R8V82B84 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.